skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:051994/0139   Pages: 14
Recorded: 03/03/2020
Attorney Dkt #:059541-000066USPX
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 1
1
Patent #:
11390625
Issue Dt:
07/19/2022
Application #:
16631416
Filing Dt:
01/15/2020
Publication #:
US20200207768
Pub Dt:
07/02/2020
Title:
Aryl-Phosphorus-Oxygen Compound As EGFR Kinase Inhibitor
Assignors
1
WU, LINGYUN
Exec Dt:
12/30/2019
2
LIU, XILE
Exec Dt:
12/30/2019
3
DING, CHARLES Z.
Exec Dt:
12/30/2019
4
CHEN, SHUHUI
Exec Dt:
12/30/2019
5
HU, LIHONG
Exec Dt:
12/31/2019
6
ZHAO, LELE
Exec Dt:
12/31/2019
7
PAN, WEI
Exec Dt:
12/30/2019
8
HU, GUOPING
Exec Dt:
12/30/2019
9
LI, JIAN
Exec Dt:
12/30/2019
10
ZHAO, NING
Exec Dt:
12/30/2019
11
ZHAO, JUN
Exec Dt:
12/09/2019
Assignee
1
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
NO. 369 YUZHOU SOUTH ROAD
JIANGSU PROVINCE
LIANYUNGANG, CHINA 222062
Correspondence name and address
NIXON PEABODY LLP
70 WEST MADISON STREET, SUITE 3500
CHICAGO, IL 60602

Search Results as of: 04/28/2024 09:51 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT